The Society for Translational Oncology (STO) is a professional association committed to speeding the discovery and translation of important new treatments in the field of cancer medicine to the practice of global oncology by:
- Bringing knowledge and strategies for critical new developments in cancer treatment to the community oncologist
- Bridging the “translational gap” between discovery and delivery of care to the patient
- Providing educational activities to improve physician competencies and strategies for screening, prevention, diagnosis, treatment, and management of patients with cancer
Founded in 2000 by leading researchers and practitioners in the trenches, STO helps improve physician competencies and strategies for screening, prevention, diagnosis, treatment, and management of patients with cancer.
Because healthcare professionals are continuously charged with staying on the cutting edge of new medical treatments and technologies, STO offers relevant and compelling programs and continuing medical education to meet those challenges.
At the intersection of academia, government, and industry, STO’s driving intention is to convene the intelligence and curiosity needed for advancing safe and effective cancer treatment at the community level.
The Society for Translational Oncology is accredited by the ACCME to provide continuing medical education for physicians.
For more information about STO and how to support our initiatives, please contact:
Carol Hardman, Carol.Hardman@sto-online.org (919) 433-0489